TPF induction chemotherapy and concomitant irradiation with cisplatin and cetuximab in unresectable squamous cell carcinoma of the head and neck. [electronic resource]
Producer: 20150629Description: 1555-61 p. digitalISSN:- 1097-0347
- Adult
- Aged
- Antibodies, Monoclonal, Humanized -- administration & dosage
- Antineoplastic Combined Chemotherapy Protocols -- administration & dosage
- Carcinoma, Squamous Cell -- mortality
- Cetuximab
- Chemoradiotherapy -- methods
- Cisplatin -- administration & dosage
- Cohort Studies
- Combined Modality Therapy
- Disease-Free Survival
- Docetaxel
- Dose-Response Relationship, Drug
- Drug Administration Schedule
- Female
- Fluorouracil -- administration & dosage
- Head and Neck Neoplasms -- mortality
- Humans
- Immunotherapy -- methods
- Induction Chemotherapy -- methods
- Infusions, Intravenous
- Kaplan-Meier Estimate
- Male
- Maximum Tolerated Dose
- Middle Aged
- Neoplasm Invasiveness -- pathology
- Neoplasm Recurrence, Local -- mortality
- Prognosis
- Squamous Cell Carcinoma of Head and Neck
- Statistics, Nonparametric
- Survival Analysis
- Taxoids -- administration & dosage
- Treatment Outcome
No physical items for this record
Publication Type: Comparative Study; Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.